You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 24, 2024

Claims for Patent: 5,681,849


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,681,849
Title: Pharmaceutical composition for topical applications
Abstract:Non-greasy topical solutions, emulsion gels or lotions comprising as the active agent a compound of formula I ##STR1## and a lower alkanol, and if desired together with a solubilizing agent or an oil phase such as isopropyl myristate are useful delivery systems.
Inventor(s): Richter; Friedrich (Schonbuhl, CH), Steiger; Michel (Bern, CH)
Assignee: Novartis AG Ltd. (Basel, CH)
Application Number:08/228,841
Patent Claims: 1. A topical pharmaceutical composition comprising as the active agent a terbinafine compound of formula I ##STR3## in free base form or in acid addition salt form, water, a lower alkanol, and a water-soluble or water-miscible nonionic surfactant, wherein no anionic surfactant is present.

2. A composition according to claim 1 containing from 50 to 85% by weight of water.

3. A composition according to claim 1 containing 5 to 35% by weight of a lower alkanol.

4. A composition according to claim 3 wherein the alkanol is ethanol.

5. A composition according to claim 1 which is substantially free of fatty material.

6. A composition according to claim 1 wherein said composition is a spray, a gel or a fluid gel.

7. A composition according to claim 1 wherein said surfactant is a polyoxyethylene fatty alcohol ether.

8. A composition according to claim 1 wherein the weight ratio of said active agent to said surfactant is from about 1:0.5 to about 1:15.

9. A composition according to claim 1 wherein the compound of formula I is present from about 0.1% to about 5% of the total weight of the composition on a w/w basis.

10. A method for the treatment of seborrhoic skin comprising administering a pharmaceutically effective amount of a composition according to claim 1 to a patient in need of such treatment.

11. A composition according to claim 7, wherein the weight ratio of said active agent to said surfactant is from about 1:0.5 to about 1:15.

12. A topical pharmaceutical composition in the form of an emulsion, said emulsion comprising an oil phase containing a terbinafine compound of the formula I ##STR4## in free base form or in acid addition salt form, and an aqueous phase comprising water, a lower alkanol, and a water-soluble or water-miscible nonionic surfactant, wherein no anionic surfactant is present.

13. A composition according to claim 12 containing isopropyl myristate as the oil phase.

14. A composition according to claim 12, wherein the weight ratio of said active agent to said oil phase is from about 1:5 to about 1:40.

15. A composition according to claim 13, wherein the ratio between the compound of formula I and the oil phase is from about 1:5 to about 1:40 on a w/w basis.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.